نتایج جستجو برای: bont/a

تعداد نتایج: 96  

2014
Larissa Bittencourt da Silva Dolarose Kulas Ali Karshenas Brian E. Cairns Flemming W. Bach Lars Arendt-Nielsen Parisa Gazerani

The effect of botulinum neurotoxin type A (BoNTA) on glutamate-evoked temporalis muscle pain and vasomotor responses was investigated in healthy men and women over a 60 day time course. Subjects participated in a pre-BoNTA session where their responses to injection of glutamate (1 M, 0.2 mL) and saline (0.2 mL) into the temporalis muscles were assessed. On Day 1, BoNTA (5 U) was injected into o...

Journal: :Acta cirurgica brasileira 2015
Cristina Pires Camargo Alfredo Luiz Jacomo Cláudia Naves Battlehner Miriam Lemos Paulo Hilário Saldiva Milton Arruda Martins Alexandre Mendonça Munhoz Rolf Gemperli

PURPOSE To investigate the effect of Botulinum toxin A (BoNTA) on skin flap viability in healthy, tobacco-exposed and diabetic rats. METHODS Ninety male Wistar rats (250-300g) were randomly divided into six groups: control+saline (C1), control+BoNTA (C2), tobacco-exposed+saline (T1), tobacco-exposed+BoNTA (T2) diabetes+saline (D1) and diabetes+BoNTA (D2). A dorsal cutaneous flap (3×10cm) was ...

Journal: :Aesthetic surgery journal 2009
Alan Matarasso David Shafer

The key points to remember about abobotulinumtoxinA are as follows: BoNTA-ABO (abobotulinumtoxinA [Dysport]; Medicis Aesthetics, Scottsdale, AZ) and BoNTA-ONA (onabotulinumtoxin A [Botox Cosmetic]; Allergan, Irvine, CA) are both derivatives of botulinum toxin A produced from different strains of the bacterium Clostridium botulinum through proprietary manufacturing processes, and both are approv...

Journal: :Acta dermato-venereologica 2015
Anna Rostedt Punga Annika Eriksson Mohammad Alimohammadi

Despite the extensive use of botulinum toxin A (BoNTA) in medical and cosmetic treatments, the potential spreading of BoNTA to surrounding tissues remains unknown. A patient with hemifacial paralysis upon blepharospasm treatment with low dose of BoNTA, prompted us to investigate the spreading effect. A randomised, double-blind study was conducted in which 5 healthy women (33-52 years) were trea...

Journal: :International journal of clinical and experimental pathology 2015
Cindy Bandala Juan Luis Terán-Melo Maricruz Anaya-Ruiz Cesar Miguel Mejía-Barradas Rene Domínguez-Rubio Paloma De la Garza-Montano Alfonso Alfaro-Rodríguez Eleazar Lara-Padilla

AIM BoNTA is used in the treatment of ophthalmological disorders, muscular hyperactivity and pain. In recent years it has been described that BoNTA reduces cellular viability and induces apoptosis in prostate cells lines. Studies about the effect of BoNTA are no well known. There have been studies about the effect of BoNTA on the expression levels of collagenase in fibroblasts, but not on its m...

Journal: :The Biochemical journal 2012
Gary W Lawrence Saak V Ovsepian Jiafu Wang K Roger Aoki J Oliver Dolly

Intracellular protein transport routes can be studied using toxins that exploit these to enter cells. BoNTA (botulinum neurotoxin type A) is a protease that binds to peripheral nerve terminals, becomes endocytosed and causes prolonged blockade of transmitter release by cleaving SNAP-25 (synaptosome-associated protein of 25 kDa). Retrograde transport of the toxin has been suggested, but not of t...

2017
Qi Tang Chang Chen Xiaqi Wang Wei Li Yan Zhang Muyao Wang Wei Jing Hang Wang Weihua Guo Weidong Tian

Adipose tissue engraftment has become a well-established therapy in plastic and reconstructive surgery used to restore age-related or injury-related soft tissue loss. However, the unpredictable absorption rates limit its further application. Some clinicians have noted that more optimal aesthetic results are achieved when botulinum toxin A (BoNTA) is applied prior to adipose tissue grafting. In ...

Journal: :Balkan medical journal 2012
Omer Karadaş Bilgin Oztürk Umit Hıdır Ulaş Yaşar Kütükçü Zeki Odabaşı

OBJECTIVE Botulinum toxin type-A (BoNTA) has been considered a treatment option for CH. The aim of this study was to assess the effectiveness of BoNTA treatment in patients with medically resistant CH. MATERIALS AND METHODS Forty patients with CH were included in the study. Patients in the BoNTA group (n=20) were administered 10 U of BoNTA bilaterally to the frontal muscles, 20 U to the tempo...

Journal: :Acta cirurgica brasileira 2016
Cristina Pires Camargo Felipe Alexandre Fernandes Michel Hyo Mi Lee Luiza Campos Moreira Silva Julio Morais Besteiro Rolf Gemperli

PURPOSE: To evaluate the effect of Botulinum Toxin A in different time of tobacco exposure. METHODS: 60 male, Wistar rats were divided into two tobacco exposure groups: a 2- month or a 4-month regimen. After this period, these two groups were subdivided as two: saline solution(SS) or botulinum toxin A(Bonta), at the time of the surgery. Seven days before the SS or Bonta injection, the animals...

2010
Yuan-Ping Pang Jon Davis Shaohua Wang Jewn Giew Park Madhusoodana P. Nambiar James J. Schmidt Charles B. Millard

Botulinum neurotoxin serotype A (BoNTA) causes a life-threatening neuroparalytic disease known as botulism that could afflict large, unprotected populations if the toxin were employed in an act of bioterrorism. Current post-exposure therapy is limited to symptomatic treatment or passive immunization that is effective for treating infant botulism at a cost of US $45,300 per treatment regimen. An...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید